Investors

Insider Transactions

Date Name Title Type Sorted Descending Shares Traded Price Range
Nov 21, 2012 stahl neil Officer Sell 24,357 173.80 - 175.49
Feb 14, 2012 stahl neil Officer Sell 31,202 107.83 - 113.47
Feb 15, 2012 stahl neil Officer Sell 21,082 107.79 - 108.09
Sep 30, 2008 stahl neil Officer Sell 10,317 21.50 - 22.15
May 13, 2013 stahl neil Officer Sell 23,038 276.71 - 277.12
Nov 23, 2012 terifay robert j Officer Sell 9,745 173.90 - 175.09
Feb 18, 2014 terifay robert j Officer Sell 12,865 331.66 - 333.79
May 8, 2013 terifay robert j Officer Sell 8,231 260.86 - 262.06
May 6, 2013 tessier-lavigne marc Director Sell 13,334 260.20 - 264.17
May 14, 2010 vagelos p roy Director Sell 20,000 26.96 - 27.19
May 6, 2013 vagelos p roy Officer Sell 13,482 263.15 - 264.19
Nov 19, 2012 vagelos p roy Officer Sell 32,500 160.59 - 161.06
Dec 2, 2013 vagelos p roy Officer Sell 95 296.11
May 23, 2014 van plew daniel p Officer Sell 5,369 295.33 - 296.70
Apr 30, 2012 van plew daniel p Officer Sell 14,442 135.94 - 136.42
Nov 16, 2012 van plew daniel p Officer Sell 18,741 153.48 - 157.44
May 7, 2013 van plew daniel p Officer Sell 13,725 260.88 - 262.15
May 7, 2013 yancopoulos george Officer Sell 100,000 261.66 - 264.21
Sep 2, 2011 aberman michael s Officer Option Execute 4,166 24.00
Sep 6, 2011 aberman michael s Officer Option Execute 8,334 24.00
Showing 61-80 of 790 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)